Cochrane systematic reviews of treatments for lung cancer

Morbidity and mortality from lung cancer is a major burden to global health. The integration of expert clinical experience, patient preference and high-quality evidence, including Cochrane systematic reviews, can only help improve outcomes from this highly lethal condition.

Saved in:
Bibliographic Details
Published inRespiratory medicine Vol. 99; no. 9; pp. 1071 - 1078
Main Authors Fong, K.M., Yang, I.A., Zimmerman, P.V., Bowman, R.V.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.09.2005
Elsevier
Elsevier Limited
Subjects
Biological and medical sciences
Carcinoma, Non-Small-Cell Lung - therapy
Carcinoma, Small Cell - therapy
Clinical trials
Evidence-Based Medicine
Humans
Lung cancer
Lung Neoplasms - diagnosis
Lung Neoplasms - prevention & control
Lung Neoplasms - therapy
Mass Screening - methods
Medical sciences
Mortality
Pneumology
Prevention
Review Literature as Topic
Smoking Cessation
Studies
Systematic reviews
Treatment
Tumors of the respiratory system and mediastinum
Prevention
Systematic reviews
Treatment
Lung cancer
Lung disease
Respiratory disease
Systematic review
Evidence-based medicine
Online AccessGet full text

Cover

More Information
Summary:Morbidity and mortality from lung cancer is a major burden to global health. The integration of expert clinical experience, patient preference and high-quality evidence, including Cochrane systematic reviews, can only help improve outcomes from this highly lethal condition.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0954-6111
1532-3064
DOI:10.1016/j.rmed.2005.05.002